X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
20
PharmaCompass offers a list of Paroxetine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Paroxetine Mesylate manufacturer or Paroxetine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Paroxetine Mesylate manufacturer or Paroxetine Mesylate supplier.
PharmaCompass also assists you with knowing the Paroxetine Mesylate API Price utilized in the formulation of products. Paroxetine Mesylate API Price is not always fixed or binding as the Paroxetine Mesylate Price is obtained through a variety of data sources. The Paroxetine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Paroxetine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paroxetine Mesylate, including repackagers and relabelers. The FDA regulates Paroxetine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paroxetine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Paroxetine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Paroxetine Mesylate supplier is an individual or a company that provides Paroxetine Mesylate active pharmaceutical ingredient (API) or Paroxetine Mesylate finished formulations upon request. The Paroxetine Mesylate suppliers may include Paroxetine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Paroxetine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Paroxetine Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Paroxetine Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Paroxetine Mesylate DMFs exist exist since differing nations have different regulations, such as Paroxetine Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Paroxetine Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Paroxetine Mesylate USDMF includes data on Paroxetine Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Paroxetine Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Paroxetine Mesylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Paroxetine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Paroxetine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Paroxetine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Paroxetine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Paroxetine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Paroxetine Mesylate suppliers with NDC on PharmaCompass.
Paroxetine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Paroxetine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Paroxetine Mesylate GMP manufacturer or Paroxetine Mesylate GMP API supplier for your needs.
A Paroxetine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Paroxetine Mesylate's compliance with Paroxetine Mesylate specifications and serves as a tool for batch-level quality control.
Paroxetine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Paroxetine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Paroxetine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Paroxetine Mesylate EP), Paroxetine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Paroxetine Mesylate USP).
Market Place
